A second lane for the men's-health conversation you're already having
If your clinic runs a men's health or TRT line, you have met the patient who wants help with low testosterone but hesitates at the tradeoffs of exogenous therapy — particularly its effect on fertility. Conventional testosterone replacement suppresses the body's own production and can impair sperm production, which matters a great deal to younger men and anyone who wants to keep the option of children open. Increasingly, those patients arrive already having read about enclomiphene and asking whether it is right for them. When your only answer is a referral out, you lose a patient who was ready to buy — and often lose them permanently, because the clinic they're referred to captures the ongoing hormone relationship, the labs, and every adjacent program that patient enrolls in over the following years.
Enclomiphene works differently: rather than supplying testosterone from outside, it stimulates the body's own hormonal axis, which is why some providers consider it for men who want to raise testosterone while potentially preserving fertility. Whether it is appropriate for a given patient is a clinical judgment your provider makes — but having it available means the conversation doesn't end with a referral out. Heally packages enclomiphene as a branded program so you can offer that second lane without assembling a pharmacy, a provider network, and the compliance workflow yourself.
Two approaches, side by side — framing, not medical advice
This is a neutral orientation for clinic owners scoping their program mix, not clinical guidance. Which approach fits a patient is always the provider's decision.
What ships when you add enclomiphene with Heally
Intake, baseline and follow-up lab guidance, and dosing frameworks built for enclomiphene, editable to your clinic's clinical philosophy.
No prescribers of your own, or gaps in some states? Heally's board-certified providers can evaluate and prescribe across all 50 states.
Enclomiphene prepared by licensed compounding pharmacies and shipped direct to your patients on a subscription cadence.
Because monitoring matters here, lab ordering and result review are part of the same workflow — not a separate vendor.
Patients experience your clinic name, logo, and domain. You own the relationship and the data.
HIPAA-compliant EHR, scheduling, video visits, refill reminders, and lifecycle messaging in a single dashboard.
Is enclomiphene a fit for your clinic's program mix?
Enclomiphene makes sense specifically for clinics that already run — or are building — a hormone or men's health line. It isn't a standalone acquisition program; it's a complement that widens the range of patients a TRT practice can say yes to. The clearest fit is a clinic that already sees fertility-minded men walking away because conventional TRT doesn't suit their goals: enclomiphene turns that lost referral into a retained patient. If a meaningful share of your inquiries come from younger men or anyone weighing testosterone against family planning, you likely have demand you're currently forfeiting.
It's a weaker fit for a clinic with no hormone offering and no provider comfortable with lab-monitored therapy, because responsible enclomiphene use assumes baseline and follow-up testing and ongoing clinical judgment — this is not a fire-and-forget e-commerce SKU. The program is strongest as one lane in a broader men's health platform that also carries TRT, so your providers can match the approach to the patient. If you want to run men's hormone health as its own consumer-facing brand, the white-label TRT and men's health brand builds the same infrastructure into a complete DTC-style experience.
The bundling advantage — one switch, not five vendor contracts
Enclomiphene is a program where the supporting infrastructure matters more than the molecule. Because monitoring is part of responsible use, you need lab ordering wired to prescribing, providers licensed where your patients live, a pharmacy that will compound and ship it, and intake that captures the right history — all integrated, not bolted together. Assembling that as separate vendor relationships is precisely the kind of overhead that keeps clinics from offering a second hormone lane at all, so they default to a single TRT protocol and lose the patients it doesn't fit.
Heally bundles the three layers competitors sell separately — HIPAA-compliant software, a 50-state provider network, and pharmacy fulfillment — with enclomiphene protocols and lab workflows already built on top. Software-only platforms leave the providers and the pharmacy to you; enterprise service vendors hand you a heavier, slower engagement than a single program warrants. Because Heally arrives with no startup fees and no long-term contract, adding enclomiphene next to your existing TRT line is a low-risk decision you can make and reverse without stranding a setup investment. You switch it on, see how many fertility-minded patients you retain, and scale from there.
"Having enclomiphene on the menu means we stop losing the younger guys who care about fertility. Before, that was a referral out; now it's a patient we keep.
— Founder, men's health clinic
Enclomiphene for these programs is prepared by licensed compounding pharmacies and is not FDA-approved for raising testosterone or preserving fertility. Any fertility-related benefit is described neutrally as a possibility a provider may consider — never promised, and never a guaranteed outcome. Candidacy, dosing, lab monitoring, and prescribing are always determined by a licensed provider after an appropriate evaluation. Keep patient-facing language free of superlative or guaranteed-result claims.
Common questions from clinic owners
Is enclomiphene an FDA-approved TRT replacement?+
No. The enclomiphene in these programs is prepared by licensed compounding pharmacies and is not FDA-approved for raising testosterone or preserving fertility. It is one option a licensed provider may consider; it should be presented that way to patients, without guarantees.
Can we position it as fertility-preserving?+
State it neutrally. Some providers consider enclomiphene for men who want to raise testosterone while <strong>potentially preserving fertility</strong>, but whether that applies to a specific patient is a clinical decision. Avoid language that promises fertility outcomes.
Do we need our own prescribers?+
No. Use your own providers, or Heally's <strong>50-state network</strong> of board-certified providers to evaluate and prescribe where you lack coverage.
How does lab monitoring work?+
Lab ordering and result review are built into the same workflow, so baseline and follow-up testing sit alongside the prescription rather than in a separate system. Providers decide the monitoring cadence per patient.
Does this compete with our existing TRT program or complement it?+
It complements it. Offering both lanes lets your providers match the approach to the patient, which keeps fertility-minded men in your practice instead of referring them elsewhere.
Do we need a hormone line already to offer this?+
It's strongest as a complement to one. Enclomiphene assumes lab-monitored care and a provider comfortable managing it, so it fits a men's health or TRT practice far better than it works as a first, standalone program.
What does it cost to launch?+
No startup fees and no long-term contract. It's recurring subscription revenue — you set your own patient price under your brand, and Heally's costs come out of it, so the program can be margin-positive from early volume.
How fast can we go live?+
Most partners launch in under a day once pricing and providers are scoped. Configuration is quick; the pacing is your own program-design decisions.
Keep exploring
Model enclomiphene alongside your TRT line
We'll show you how a second hormone lane affects patient retention and recurring revenue — with no startup fees to launch.
Schedule a DemoSchedule a demo
See how quickly you can run your whole clinic on Heally — software, a 50-state provider network, and pharmacy fulfillment, handled from day one.